Clinical trial

Effect of Lugol's Solution in the Patients With Graves' Disease

NCT00432146 · Istanbul University, Other · Completed

Key facts

NCT number NCT00432146
Title Effect of Lugol's Solution in the Patients With Graves' Disease
Official title Positive Effect of Lugol's Solution on the Blood Flow and Microvessel Density of Thyroid Gland in the Patients With Graves' Disease
Lead sponsor Istanbul University, Other
Status Completed
Study type Observational
Conditions Graves Disease
Intervention type Drug
Interventions lugol's solution
Enrollment 36
Start date Sep 1, 2005
Completion Sep 1, 2006
First posted Feb 7, 2007
Last update posted Oct 20, 2008

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies